Forum Update: Supporting Community-Led Discussion
The forum was created as a space for shared learning and peer support, and as the community grows, we want to lean more fully into that purpose.
Going forward, PAAB will be taking a more listening-first role in forum discussions. Rather than responding immediately to every question, we’ll be encouraging members to engage with one another, share experiences, and help build collective understanding. PAAB will continue to monitor conversations and will step in to:
- Correct any misunderstandings
- Provide guidance when questions remain unanswered after a few days
- Support discussions where official clarification is needed
Our goal is to foster a collaborative, trusted community where knowledge is shared and strengthened by everyone’s contributions.
Thank you for being part of the conversation.
International Guidelines with a large Canadian presence in the committee
-
Hi! We are interested in using a set of International Guidelines to provide messages about its recommendations and to make place-in-therapy claims about our product. While we note that international guidelines are generally not accepted and that PAAB favours Canadian and American guidelines, over 10 of the authors on these guidelines (including the lead author) are Canadian. Furthermore, because these guidelines are for a rare disease, there is no Canadian authoritative medical body that focuses on the disease, so getting "endorsement" from such a body may be difficult. Given these circumstances, would PAAB be a bit more flexible regarding the use of these guidelines?
-
Good Morning @dmauri
This is a specific review question. Please submit the guidelines and proposed product claims. This can be done in a full submission or an opinion if you’d like further clarification prior to building out tools.
